I helped design and implement SHOPS Plus India’s first e-pharmacy–enabled TB drug delivery model, developed with the Government of Madhya Pradesh and Medlife International. The pilot created a patient-centric system that delivered free anti-TB medicines and home sputum testing directly to patients’ doorsteps in Jabalpur, Indore, and Bhopal, reducing travel barriers, stigma, and loss to follow-up. I contributed to the service design, partnership structuring, and workflow alignment connecting private providers, e-pharmacy operations, Medlife’s call center, and state TB offices. The model integrated WhatsApp-based prescription uploads, scheduled follow-up calls, digital ordering, lab reporting through Nikshay, and logistics coordination to ensure continuity of care. A key focus of my role was strengthening government engagement so the model aligned with state and national TB guidelines. SHOPS Plus supported the Madhya Pradesh government in building procurement and budgeting processes to sustain the system, and the national program incorporated supportive partnership language into official guidance—paving the way for scale-up. During COVID-19, the model proved particularly valuable. With essential-service exemptions, Medlife continued deliveries when many facilities were unable to operate at full capacity, ensuring uninterrupted treatment for TB patients. The pilot’s results demonstrated strong feasibility: • 2,800+ TB patients received doorstep delivery of medicines • 600+ home-collected sputum samples were tested • Loss to follow-up remained only 1.6% over eight months • 2,600+ patients were linked to nutrition support (DBT) This work showcased the potential of digitally enabled, logistics-supported delivery models to complement public TB services and demonstrated my ability to architect scalable, patient-centred, cross-sector health access solutions.